Peer Review reports
From: Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
| Original Submission | ||
|---|---|---|
| 13 Oct 2021 | Submitted | Original manuscript |
| 10 Dec 2021 | Reviewed | Reviewer Report |
| 24 Jan 2022 | Reviewed | Reviewer Report |
| 4 Feb 2022 | Author responded | Author comments - Chuansheng Zheng |
| 9 Feb 2022 | Author responded | Author comments - Chuansheng Zheng |
| Resubmission - Version 2 | ||
| 4 Feb 2022 | Submitted | Manuscript version 2 |
| Publishing | ||
| 21 Feb 2022 | Editorially accepted | |
| 14 Mar 2022 | Article published | 10.1186/s12885-022-09325-6 |
You can find further information about peer review here.